OR WAIT null SECS
Kevin Gopal is Pharmaceutical Executive's international correspondent, covering pharma and regulatory issues around the word. He is also a political columnist for North West Business Insider, one of the UK's leading regional business magazines. He started his career as a journalist at SiYu, the UK's Chinese community magazine, before joining the PE staff.
Singapore—Lilly’s decision to set up a Singapore R&D center to focus on systems biology is the latest in a series of moves that have put the Far East island on the biotech map.